Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Extensive drug resistance in malaria and tuberculosis.

Wongsrichanalai C, Varma JK, Juliano JJ, Kimerling ME, MacArthur JR.

Emerg Infect Dis. 2010 Jul;16(7):1063-7. doi: 10.3201/eid1607.091840.

2.

[Combined antimalarial therapy using artemisinin].

Majori G.

Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.

PMID:
15305693
3.

Drug repositioning in the treatment of malaria and TB.

Nzila A, Ma Z, Chibale K.

Future Med Chem. 2011 Sep;3(11):1413-26. doi: 10.4155/fmc.11.95. Review.

PMID:
21879845
4.

Clinical and operational value of the extensively drug-resistant tuberculosis definition.

Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC; SMIRA/TBNET Study Group..

Eur Respir J. 2007 Oct;30(4):623-6. Epub 2007 Aug 9.

5.

Drug resistance among malaria and other parasites.

Barat LM, Bloland PB.

Infect Dis Clin North Am. 1997 Dec;11(4):969-87. Review.

PMID:
9421710
6.

The management of tuberculosis: epidemiology, resistance and monitoring.

Bang D.

Dan Med Bull. 2010 Nov;57(11):B4213. Review.

PMID:
21055374
7.

[Drug resistant tuberculosis].

Zwolska Z, Augustynowicz-Kopeć E.

Pol Merkur Lekarski. 2011 May;30(179):362-6. Review. Polish.

PMID:
21675144
8.

Tuberculosis drug resistance: a global threat.

Nachega JB, Chaisson RE.

Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S24-30.

PMID:
12516027
9.

World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ.

Malar J. 2007 Sep 6;6:121.

11.

How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance.

Hastings I.

Trends Parasitol. 2011 Feb;27(2):67-72. doi: 10.1016/j.pt.2010.09.005.

PMID:
20971040
12.

Treatment of multidrug-resistant tuberculosis in Thailand.

Maranetra KN.

Chemotherapy. 1996;42 Suppl 3:10-5; discussion 30-3. Review.

PMID:
8980862
13.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
14.

Antimalarial compounds: from bench to bedside.

Olliaro PL, Taylor WR.

J Exp Biol. 2003 Nov;206(Pt 21):3753-9. Review.

15.

Multidrug-resistant tuberculosis.

Zager EM, McNerney R.

BMC Infect Dis. 2008 Jan 25;8:10. doi: 10.1186/1471-2334-8-10.

16.

Multi-drug resistant tuberculosis: an iatrogenic problem.

Kant S, Maurya AK, Kushwaha RA, Nag VL, Prasad R.

Biosci Trends. 2010 Apr;4(2):48-55. Review.

17.

Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.

Mitrzyk BM.

Pharmacotherapy. 2008 Oct;28(10):1243-54. doi: 10.1592/phco.28.10.1243. Review.

PMID:
18823220
18.

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2006 Mar 24;55(11):301-5.

19.

Worldwide emergence of extensively drug-resistant tuberculosis.

Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP.

Emerg Infect Dis. 2007 Mar;13(3):380-7.

20.

Delaying antimalarial drug resistance with combination chemotherapy.

White NJ.

Parassitologia. 1999 Sep;41(1-3):301-8. Review.

PMID:
10697872

Supplemental Content

Support Center